A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
Homma
J Y
JY
Tanimoto
H
H
D036002:ADP Ribose Transferases; D000907:Antibodies, Bacterial / Q000032:analysis; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D001428:Bacterial Vaccines / Q000276:immunology*; D001988:Bronchiolitis / Q000517:prevention & control; D004731:Endotoxins / Q000276:immunology*; D005098:Exotoxins / Q000276:immunology*; D006801:Humans; D008666:Metalloendopeptidases; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D012697:Serine Endopeptidases / Q000276:immunology*; D014121:Toxoids / Q000276:immunology; D014611:Vaccination; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D004731:Endotoxins; D005098:Exotoxins; D008666:Metalloendopeptidases; D012697:Serine Endopeptidases; D014121:Toxoids; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A; C016628:protein-rich endotoxin; C038495:Pseudomonas serine proteinase; C043859:pseudolysin, Pseudomonas aeruginosa